Biomatter
EMEA
Vilnius
,
Lithuania
Startup
FOUNDED
2018
HEADCOUNT
21-100
FUNDING
Seed
Keywords:
enzymes, AI/ML, directed_evolution
BUSINESS
Designs novel enzymes and proteins using an AI-powered platform for applications in health, sustainable chemistry, food, personal care, and industrial manufacturing. Proprietary Intelligent Architecture platform designs enzymes bottom-up from first principles, specifying desired characteristics and building the enzyme de novo rather than modifying natural templates. Also offers LYNX Enzyme Optimization, an AI/physics-based tool for improving activity, stability, and yield from a single sequence input. Customers include Thermo Fisher Scientific, BASF, Neogen, and Kirin (collaboration on enzymatic HMO production for infant nutrition). Applications span chemical biomanufacturing, agriculture, food, and life sciences. Raised €6.5M seed (August 2024).
BIOTECH INVOLVEMENT
Core; Vilnius-based generative-AI protein design company using its Intelligent Architecture platform to design enzymes and proteins for health, sustainable chemistry, food, personal care, and industrial manufacturing, with experimental validation in collaboration with partners.
TECHNOLOGY PLATFORM
Intelligent Architecture (generative AI + modeling); protein engineering
PRIMARY PRODUCTS
Custom-designed enzymes and biocatalysts for industry partners